▶ 調査レポート

世界の肝細胞増殖因子産業2020-2026

• 英文タイトル:Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

Global Hepatocyte Growth Factor Industry Research Report, Growth Trends and Competitive Analysis 2020-2026「世界の肝細胞増殖因子産業2020-2026」(市場規模、市場予測)調査レポートです。• レポートコード:D0MA3011869
• 出版社/出版日:QYResearch / 2020年3月25日
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥509,600 (USD4,900)▷ お問い合わせ
  Multi User¥764,400 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,019,200 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、肝細胞増殖因子の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、肝細胞増殖因子のグローバル市場動向、メーカー別競争状況、種類別市場規模(タイプI、タイプII)、用途別市場規模(腫瘍学、心血管、中枢神経系、血液疾患、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・肝細胞増殖因子の種類別市場2015-2026:タイプI、タイプII
・肝細胞増殖因子の用途別市場2015-2026:腫瘍学、心血管、中枢神経系、血液疾患、その他
・肝細胞増殖因子の北米市場分析
・肝細胞増殖因子のアジア市場分析
・肝細胞増殖因子の中南米市場分析
・肝細胞増殖因子の中東・アフリカ市場分析
・関連企業情報:ViroMed、AnGes MG、M3 Biotechnology、AVEO Pharmaceuticals、Molecular Partners、Yooyoung Pharm、F-star、Galaxy Biotech、Kringle Pharma
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
In 2019, the global Hepatocyte Growth Factor market size was US$ 48 million and is forecast to US$ 70 million in 2026, growing at a CAGR of 5.7% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Hepatocyte Growth Factor.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hepatocyte Growth Factor market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hepatocyte Growth Factor market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hepatocyte Growth Factor market. Readers of the report can become informed about current and future trends of the global Hepatocyte Growth Factor market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Hepatocyte Growth Factor markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Hepatocyte Growth Factor market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Hepatocyte Growth Factor market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Hepatocyte Growth Factor market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Hepatocyte Growth Factor market is segmented into
Type I
Type II

Market Segment by Application, the Hepatocyte Growth Factor market is segmented into
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others

This report includes the following manufacturers; we can also add the other companies as you want.
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma

The study objectives are:
To analyze and research the global Hepatocyte Growth Factor status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Hepatocyte Growth Factor manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hepatocyte Growth Factor are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Hepatocyte Growth Factor Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Hepatocyte Growth Factor Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Type I
1.3.3 Type II
1.4 Market Segment by Application
1.4.1 Global Hepatocyte Growth Factor Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Oncology
1.4.3 Cardiovascular
1.4.4 Central Nervous System
1.4.5 Hematological Disorders
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Hepatocyte Growth Factor Revenue (2015-2026)
2.1.1 Global Hepatocyte Growth Factor Revenue (2015-2026)
2.1.2 Global Hepatocyte Growth Factor Sales (2015-2026)
2.2 Hepatocyte Growth Factor Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Hepatocyte Growth Factor Sales by Regions (2015-2020)
2.2.2 Global Hepatocyte Growth Factor Revenue by Regions (2015-2020)
2.3 Global Top Hepatocyte Growth Factor Regions (Countries) Ranking by Market Size
2.4 Hepatocyte Growth Factor Industry Trends
2.4.1 Hepatocyte Growth Factor Market Top Trends
2.4.2 Market Drivers
2.4.3 Hepatocyte Growth Factor Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Hepatocyte Growth Factor Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Hepatocyte Growth Factor Manufacturers by Sales (2015-2020)
3.1.1 Global Hepatocyte Growth Factor Sales by Manufacturers (2015-2020)
3.1.2 Global Hepatocyte Growth Factor Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Hepatocyte Growth Factor Sales in 2019
3.2 Global Top Manufacturers Hepatocyte Growth Factor by Revenue
3.2.1 Global Hepatocyte Growth Factor Revenue by Manufacturers (2015-2020)
3.2.2 Global Hepatocyte Growth Factor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatocyte Growth Factor Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatocyte Growth Factor as of 2019)
3.4 Global Hepatocyte Growth Factor Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hepatocyte Growth Factor Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hepatocyte Growth Factor Market
3.7 Key Manufacturers Hepatocyte Growth Factor Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hepatocyte Growth Factor Historic Market Review by Type (2015-2020)
4.1.2 Global Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
4.1.3 Global Hepatocyte Growth Factor Revenue Market Share by Type (2015-2020)
4.1.4 Hepatocyte Growth Factor Price by Type (2015-2020)
4.1 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Hepatocyte Growth Factor Sales Forecast by Type (2021-2026)
4.2.3 Global Hepatocyte Growth Factor Revenue Forecast by Type (2021-2026)
4.2.4 Hepatocyte Growth Factor Price Forecast by Type (2021-2026)

5 Global Hepatocyte Growth Factor Market Size by Application
5.1 Global Hepatocyte Growth Factor Historic Market Review by Application (2015-2020)
5.1.2 Global Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
5.1.3 Global Hepatocyte Growth Factor Revenue Market Share by Application (2015-2020)
5.1.4 Hepatocyte Growth Factor Price by Application (2015-2020)
5.2 Global Hepatocyte Growth Factor Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Hepatocyte Growth Factor Sales Forecast by Application (2021-2026)
5.2.3 Global Hepatocyte Growth Factor Revenue Forecast by Application (2021-2026)
5.2.4 Hepatocyte Growth Factor Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hepatocyte Growth Factor Breakdown Data by Company
6.2 North America Hepatocyte Growth Factor Breakdown Data by Type
6.3 North America Hepatocyte Growth Factor Breakdown Data by Application
6.4 North America Hepatocyte Growth Factor Breakdown Data by Countries
6.4.1 North America Hepatocyte Growth Factor Sales by Countries
6.4.2 North America Hepatocyte Growth Factor Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Hepatocyte Growth Factor Breakdown Data by Company
7.2 Europe Hepatocyte Growth Factor Breakdown Data by Type
7.3 Europe Hepatocyte Growth Factor Breakdown Data by Application
7.4 Europe Hepatocyte Growth Factor Breakdown Data by Countries
7.4.1 Europe Hepatocyte Growth Factor Sales by Countries
7.4.2 Europe Hepatocyte Growth Factor Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hepatocyte Growth Factor Breakdown Data by Company
8.2 Asia Pacific Hepatocyte Growth Factor Breakdown Data by Type
8.3 Asia Pacific Hepatocyte Growth Factor Breakdown Data by Application
8.4 Asia Pacific Hepatocyte Growth Factor Breakdown Data by Regions
8.4.1 Asia Pacific Hepatocyte Growth Factor Sales by Regions
8.4.2 Asia Pacific Hepatocyte Growth Factor Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Hepatocyte Growth Factor Breakdown Data by Company
9.2 Latin America Hepatocyte Growth Factor Breakdown Data by Type
9.3 Latin America Hepatocyte Growth Factor Breakdown Data by Application
9.4 Latin America Hepatocyte Growth Factor Breakdown Data by Countries
9.4.1 Latin America Hepatocyte Growth Factor Sales by Countries
9.4.2 Latin America Hepatocyte Growth Factor Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Hepatocyte Growth Factor Breakdown Data by Type
10.2 Middle East and Africa Hepatocyte Growth Factor Breakdown Data by Application
10.3 Middle East and Africa Hepatocyte Growth Factor Breakdown Data by Countries
10.3.1 Middle East and Africa Hepatocyte Growth Factor Sales by Countries
10.3.2 Middle East and Africa Hepatocyte Growth Factor Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 ViroMed
11.1.1 ViroMed Corporation Information
11.1.2 ViroMed Business Overview and Total Revenue (2019 VS 2018)
11.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 ViroMed Hepatocyte Growth Factor Products and Services
11.1.5 ViroMed SWOT Analysis
11.1.6 ViroMed Recent Developments
11.2 AnGes MG
11.2.1 AnGes MG Corporation Information
11.2.2 AnGes MG Business Overview and Total Revenue (2019 VS 2018)
11.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 AnGes MG Hepatocyte Growth Factor Products and Services
11.2.5 AnGes MG SWOT Analysis
11.2.6 AnGes MG Recent Developments
11.3 M3 Biotechnology
11.3.1 M3 Biotechnology Corporation Information
11.3.2 M3 Biotechnology Business Overview and Total Revenue (2019 VS 2018)
11.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 M3 Biotechnology Hepatocyte Growth Factor Products and Services
11.3.5 M3 Biotechnology SWOT Analysis
11.3.6 M3 Biotechnology Recent Developments
11.4 AVEO Pharmaceuticals
11.4.1 AVEO Pharmaceuticals Corporation Information
11.4.2 AVEO Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Products and Services
11.4.5 AVEO Pharmaceuticals SWOT Analysis
11.4.6 AVEO Pharmaceuticals Recent Developments
11.5 Molecular Partners
11.5.1 Molecular Partners Corporation Information
11.5.2 Molecular Partners Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Molecular Partners Hepatocyte Growth Factor Products and Services
11.5.5 Molecular Partners SWOT Analysis
11.5.6 Molecular Partners Recent Developments
11.6 Yooyoung Pharm
11.6.1 Yooyoung Pharm Corporation Information
11.6.2 Yooyoung Pharm Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Yooyoung Pharm Hepatocyte Growth Factor Products and Services
11.6.5 Yooyoung Pharm SWOT Analysis
11.6.6 Yooyoung Pharm Recent Developments
11.7 F-star
11.7.1 F-star Corporation Information
11.7.2 F-star Business Overview and Total Revenue (2019 VS 2018)
11.7.3 F-star Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 F-star Hepatocyte Growth Factor Products and Services
11.7.5 F-star SWOT Analysis
11.7.6 F-star Recent Developments
11.8 Galaxy Biotech
11.8.1 Galaxy Biotech Corporation Information
11.8.2 Galaxy Biotech Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Galaxy Biotech Hepatocyte Growth Factor Products and Services
11.8.5 Galaxy Biotech SWOT Analysis
11.8.6 Galaxy Biotech Recent Developments
11.9 Kringle Pharma
11.9.1 Kringle Pharma Corporation Information
11.9.2 Kringle Pharma Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Kringle Pharma Hepatocyte Growth Factor Products and Services
11.9.5 Kringle Pharma SWOT Analysis
11.9.6 Kringle Pharma Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Hepatocyte Growth Factor Sales Channels
12.2.2 Hepatocyte Growth Factor Distributors
12.3 Hepatocyte Growth Factor Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.1.1 Global Hepatocyte Growth Factor Sales Forecast by Regions (2021-2026)
13.1.2 Global Hepatocyte Growth Factor Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.2.2 North America Hepatocyte Growth Factor Revenue Forecast (2021-2026)
13.2.3 North America Hepatocyte Growth Factor Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.3.2 Europe Hepatocyte Growth Factor Revenue Forecast (2021-2026)
13.3.3 Europe Hepatocyte Growth Factor Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.4.2 Asia Pacific Hepatocyte Growth Factor Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Hepatocyte Growth Factor Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.5.2 Latin America Hepatocyte Growth Factor Revenue Forecast (2021-2026)
13.5.3 Latin America Hepatocyte Growth Factor Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Hepatocyte Growth Factor Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Hepatocyte Growth Factor Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Hepatocyte Growth Factor Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Hepatocyte Growth Factor Key Market Segments
Table 2. Ranking of Global Top Hepatocyte Growth Factor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatocyte Growth Factor Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. Global Hepatocyte Growth Factor Market Share by Application 2019-2025 (K Units)
Table 7. Global Hepatocyte Growth Factor Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Hepatocyte Growth Factor Sales by Regions 2015-2020 (K Units)
Table 9. Global Hepatocyte Growth Factor Sales Market Share by Regions 2015-2020
Table 10. Global Hepatocyte Growth Factor Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Hepatocyte Growth Factor Revenue Market Share by Regions 2015-2020
Table 12. Top Hepatocyte Growth Factor Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Hepatocyte Growth Factor Key Drivers: Impact Analysis (2021-2026)
Table 15. Hepatocyte Growth Factor Key Challenges
Table 16. Main Points Interviewed from Key Hepatocyte Growth Factor Players: Views for Future
Table 17. Global Hepatocyte Growth Factor Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Hepatocyte Growth Factor Sales Share by Manufacturers (2015-2020)
Table 19. Hepatocyte Growth Factor Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Hepatocyte Growth Factor Revenue Share by Manufacturers (2015-2020)
Table 21. Global Hepatocyte Growth Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatocyte Growth Factor as of 2019)
Table 23. Key Manufacturers Hepatocyte Growth Factor Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Hepatocyte Growth Factor Plants/Factories Distribution
Table 25. Key Manufacturers Hepatocyte Growth Factor Area Served
Table 26. Date of Key Manufacturers Enter into Hepatocyte Growth Factor Market
Table 27. Key Manufacturers Hepatocyte Growth Factor Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hepatocyte Growth Factor Sales (K Units) by Type (2015-2020)
Table 30. Global Hepatocyte Growth Factor Sales Share by Type (2015-2020)
Table 31. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 32. Global Hepatocyte Growth Factor Price (K Units) by Type (2015-2020)
Table 33. Global Hepatocyte Growth Factor Sales (K Units) by Type (2021-2026)
Table 34. Global Hepatocyte Growth Factor Sales Share by Type (2021-2026)
Table 35. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 36. Global Hepatocyte Growth Factor Revenue Share by Type (2021-2026)
Table 37. Global Hepatocyte Growth Factor Price (K Units) by Type (2021-2026)
Table 38. Global Hepatocyte Growth Factor Sales (K Units) by Application (2015-2020)
Table 39. Global Hepatocyte Growth Factor Sales Share by Application (2015-2020)
Table 40. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 41. Global Hepatocyte Growth Factor Price by Application 2015-2020 (USD/Unit)
Table 42. Global Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 43. Global Hepatocyte Growth Factor Sales Share by Application (2015-2020)
Table 44. Global Hepatocyte Growth Factor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 45. Global Hepatocyte Growth Factor Revenue Share by Application (2021-2026)
Table 46. Global Hepatocyte Growth Factor Price (K Units) by Application (2021-2026)
Table 47. North America Hepatocyte Growth Factor Sales by Company (2015-2020) (K Units)
Table 48. North America Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 49. North America Hepatocyte Growth Factor Sales by Type (2015-2020) (K Units)
Table 50. North America Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 51. North America Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 52. North America Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 53. North America Hepatocyte Growth Factor Sales by Countries (2015-2020) (K Units)
Table 54. North America Hepatocyte Growth Factor Sales Market Share by Countries (2015-2020)
Table 55. North America Hepatocyte Growth Factor Revenue by Countries (2015-2020) (Million US$)
Table 56. North America Hepatocyte Growth Factor Revenue Market Share by Countries (2015-2020)
Table 57. Europe Hepatocyte Growth Factor Sales by Company (2015-2020) (K Units)
Table 58. Europe Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 59. Europe Hepatocyte Growth Factor Sales by Type (2015-2020) (K Units)
Table 60. Europe Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 61. Europe Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 62. Europe Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 63. Europe Hepatocyte Growth Factor Sales by Countries (2015-2020) (K Units)
Table 64. Europe Hepatocyte Growth Factor Sales Market Share by Countries (2015-2020)
Table 65. Europe Hepatocyte Growth Factor Revenue by Countries (2015-2020) (Million US$)
Table 66. Europe Hepatocyte Growth Factor Revenue Market Share by Countries (2015-2020)
Table 67. Asia Pacific Hepatocyte Growth Factor Sales by Regions (2015-2020) (K Units)
Table 68. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Regions (2015-2020)
Table 69. Asia Pacific Hepatocyte Growth Factor Sales by Type (2015-2020) (K Units)
Table 70. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 71. Asia Pacific Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 72. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 73. Asia Pacific Hepatocyte Growth Factor Sales by Countries (2015-2020) (K Units)
Table 74. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Hepatocyte Growth Factor Revenue by Regions (2015-2020) (Million US$)
Table 76. Asia Pacific Hepatocyte Growth Factor Revenue Market Share by Regions (2015-2020)
Table 77. Latin America Hepatocyte Growth Factor Sales by Company (2015-2020) (K Units)
Table 78. Latin America Hepatocyte Growth Factor Sales Market Share by Company (2015-2020)
Table 79. Latin America Hepatocyte Growth Factor Sales by Type (2015-2020) (K Units)
Table 80. Latin America Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 81. Latin America Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 82. Latin America Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 83. Latin America Hepatocyte Growth Factor Sales by Countries (2015-2020) (K Units)
Table 84. Latin America Hepatocyte Growth Factor Sales Market Share by Countries (2015-2020)
Table 85. Latin America Hepatocyte Growth Factor Revenue by Countries (2015-2020) (Million US$)
Table 86. Latin America Hepatocyte Growth Factor Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Hepatocyte Growth Factor Sales by Type (2015-2020) (K Units)
Table 88. Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Type (2015-2020)
Table 89. Middle East and Africa Hepatocyte Growth Factor Sales by Application (2015-2020) (K Units)
Table 90. Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Application (2015-2020)
Table 91. Middle East and Africa Hepatocyte Growth Factor Sales by Countries (2015-2020) (K Units)
Table 92. Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Hepatocyte Growth Factor Revenue by Countries (2015-2020) (Million US$)
Table 94. Middle East and Africa Hepatocyte Growth Factor Revenue Market Share by Countries (2015-2020)
Table 95. ViroMed Company Details
Table 96. ViroMed Description and Business Overview
Table 97. ViroMed Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. ViroMed Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 99. ViroMed Hepatocyte Growth Factor Sales Market Share in Global Market
Table 100. ViroMed Recent Development
Table 101. AnGes MG Company Details
Table 102. AnGes MG Description and Business Overview
Table 103. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. AnGes MG Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 105. AnGes MG Hepatocyte Growth Factor Sales Market Share in Global Market
Table 106. AnGes MG Recent Development
Table 107. M3 Biotechnology Company Details
Table 108. M3 Biotechnology Description and Business Overview
Table 109. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. M3 Biotechnology Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 111. M3 Biotechnology Hepatocyte Growth Factor Sales Market Share in Global Market
Table 112. M3 Biotechnology Recent Development
Table 113. AVEO Pharmaceuticals Company Details
Table 114. AVEO Pharmaceuticals Description and Business Overview
Table 115. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 117. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales Market Share in Global Market
Table 118. AVEO Pharmaceuticals Recent Development
Table 119. Molecular Partners Company Details
Table 120. Molecular Partners Description and Business Overview
Table 121. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Molecular Partners Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 123. Molecular Partners Hepatocyte Growth Factor Sales Market Share in Global Market
Table 124. Molecular Partners Recent Development
Table 125. Yooyoung Pharm Company Details
Table 126. Yooyoung Pharm Description and Business Overview
Table 127. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Yooyoung Pharm Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 129. Yooyoung Pharm Hepatocyte Growth Factor Sales Market Share in Global Market
Table 130. Yooyoung Pharm Recent Development
Table 131. F-star Company Details
Table 132. F-star Description and Business Overview
Table 133. F-star Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. F-star Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 135. F-star Hepatocyte Growth Factor Sales Market Share in Global Market
Table 136. F-star Recent Development
Table 137. Galaxy Biotech Company Details
Table 138. Galaxy Biotech Description and Business Overview
Table 139. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Galaxy Biotech Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 141. Galaxy Biotech Hepatocyte Growth Factor Sales Market Share in Global Market
Table 142. Galaxy Biotech Recent Development
Table 143. Kringle Pharma Company Details
Table 144. Kringle Pharma Description and Business Overview
Table 145. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Kringle Pharma Hepatocyte Growth Factor Sales Growth Rate (2015-2020)
Table 147. Kringle Pharma Hepatocyte Growth Factor Sales Market Share in Global Market
Table 148. Kringle Pharma Recent Development
Table 149. Hepatocyte Growth Factor Distributors List
Table 150. Hepatocyte Growth Factor Customers List
Table 151. Global Hepatocyte Growth Factor Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 152. Global Hepatocyte Growth Factor Sales Forecast by Type 2021-2026 (K Units)
Table 153. Global Hepatocyte Growth Factor Sales Forecast by Application 2021-2026 (K Units)
Table 154. Global Hepatocyte Growth Factor Sales Forecast by Regions 2021-2026 (K Units)
Table 155. Global Hepatocyte Growth Factor Revenue Forecast by Regions 2021-2026 (Million US$)
Table 156. North America Hepatocyte Growth Factor Sales Forecast by Countries 2021-2026 (K Units)
Table 157. North America Hepatocyte Growth Factor Revenue Forecast by Countries 2021-2026
Table 158. Europe Hepatocyte Growth Factor Sales Forecast by Countries 2021-2026 (K Units)
Table 159. Europe Hepatocyte Growth Factor Revenue Market Share Forecast by Countries 2021-2026
Table 160. Asia Pacific Hepatocyte Growth Factor Sales Forecast by Regions 2021-2026 (K Units)
Table 161. Asia Pacific Hepatocyte Growth Factor Revenue Forecast by Regions 2021-2026 (Million US$)
Table 162. Latin America Hepatocyte Growth Factor Sales Forecast by Countries 2021-2026 (K Units)
Table 163. Latin America Hepatocyte Growth Factor Revenue Forecast by Countries 2021-2026 (Million US$)
Table 164. Middle East and Africa Hepatocyte Growth Factor Sales Forecast by Regions 2021-2026 (K Units)
Table 165. Middle East and Africa Hepatocyte Growth Factor Revenue Forecast by Regions 2021-2026 (Million US$)
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatocyte Growth Factor Product Picture
Figure 2. Global Hepatocyte Growth Factor Sales Market Shar by Type 2015-2026
Figure 3. Type I Figures
Figure 4. Type II Figures
Figure 5. Global Hepatocyte Growth Factor Sales Market Share by Application in 2019 & 2026
Figure 6. Oncology Use Case
Figure 7. Cardiovascular Use Case
Figure 8. Central Nervous System Use Case
Figure 9. Hematological Disorders Use Case
Figure 10. Others Use Case
Figure 11. Hepatocyte Growth Factor Report Years Considered
Figure 12. Global Hepatocyte Growth Factor Market Size 2015-2026 (Million US$)
Figure 13. Global Hepatocyte Growth Factor Sales 2015-2020 (K Units)
Figure 14. Global Hepatocyte Growth Factor Market Size Market Share by Regions 2015-2020
Figure 15. Global Hepatocyte Growth Factor Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hepatocyte Growth Factor Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatocyte Growth Factor Sales in 2019
Figure 19. Hepatocyte Growth Factor Value Share by Manufacturers in 2019
Figure 20. Hepatocyte Growth Factor Revenue Share by Manufacturers In 2019
Figure 21. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Hepatocyte Growth Factor Revenue Share by Type (2015-2020)
Figure 23. Global Hepatocyte Growth Factor Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Hepatocyte Growth Factor Market Share by Price Range (2015-2020)
Figure 25. Global Hepatocyte Growth Factor Revenue Share by Application (2015-2020)
Figure 26. Global Hepatocyte Growth Factor Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Hepatocyte Growth Factor Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Hepatocyte Growth Factor Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Hepatocyte Growth Factor Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Hepatocyte Growth Factor Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Hepatocyte Growth Factor Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Hepatocyte Growth Factor Sales Growth Rate (2015-2020) (K Units)
Figure 56. ViroMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AnGes MG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. M3 Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AVEO Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Molecular Partners Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Yooyoung Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. F-star Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Galaxy Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Kringle Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Hepatocyte Growth Factor Value Chain
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. North America Hepatocyte Growth Factor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. North America Hepatocyte Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Europe Hepatocyte Growth Factor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Europe Hepatocyte Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Asia Pacific Hepatocyte Growth Factor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Asia Pacific Hepatocyte Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Latin America Hepatocyte Growth Factor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Latin America Hepatocyte Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Middle East and Africa Hepatocyte Growth Factor Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 77. Middle East and Africa Hepatocyte Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed